Phase 4 Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with moderate or severe hemophilia A
- You are between 14 and 66 years old
- You have tested positive for inhibitors (antibodies that block hemophilia treatment) at two separate check-up visits in a row
- Your inhibitor level was measured above 10 BU (a specific unit used to measure inhibitor strength) at your screening appointment
Who may not be able to join:
- You are allergic to any of the ingredients in the study drug, or you have an allergy to hamster proteins
- You have another immune system condition, or you are currently taking medicines that suppress your immune system for another health condition
- You have previously tried a full course of immune tolerance induction (ITI) therapy — a treatment to reduce inhibitors — and it did not work
- You have had difficulty following medical treatment plans or keeping appointments in the past (confirm with trial site)
- The trial doctors have any other concerns that they feel make participation unsuitable for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lei Zhang, Chinese Academy of Medical Science and Blood Disease Hospital
Phone: +8613820261971
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
success rate of ITI success rate of ITI success rate of ITI success rate of ITI; Success rate and partial success rate of ITI after 3-month treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.